Stéphane Epelbaum

6PUBLICATIONS

14CO-AUTHORS

Disease surveillanceAutomotive engineering materialsGerman languageEthical use of new technologyMemory and attention

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 30, 2026

Sleep-like slow waves during resting-state: A promising EEG biomarker of amyloid and neurodegeneration in preclinical Alzheimer's disease.

|Mar 09, 2022

The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease.

Timothy Daly, Stéphane Epelbaum

|May 13, 2021

Primary Progressive Aphasia Associated With <i>GRN</i> Mutations: New Insights Into the Nonamyloid Logopenic Variant.

Dario Saracino, Sophie Ferrieux, Marie Noguès-Lassiaille

|Jan 18, 2021

The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.

Timothy Daly, Ignacio Mastroleo, David Gorski

|Oct 15, 2020

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD.

Federica Cacciamani, Luisa Sambati, Marion Houot

|Jun 27, 2019

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.

Stéphane Epelbaum, Claire Paquet, Jacques Hugon

Pageof 1

Frequent Collaborators

Timothy Daly

Ignacio Mastroleo

David Gorski

Dario Saracino

Pierre Champetier

Filipa Raposo Pereira

Rubén Herzog

Maximilien Chaumon

Marion Houot

Maxime Locatelli

Frequent Collaborators

Timothy Daly

Ignacio Mastroleo

David Gorski

Dario Saracino